CODEINE, ASPIRIN, APAP FORMULA NO. 4 Drug Patent Profile
✉ Email this page to a colleague
When do Codeine, Aspirin, Apap Formula No. 4 patents expire, and when can generic versions of Codeine, Aspirin, Apap Formula No. 4 launch?
Codeine, Aspirin, Apap Formula No. 4 is a drug marketed by Scherer Labs and is included in one NDA.
The generic ingredient in CODEINE, ASPIRIN, APAP FORMULA NO. 4 is acetaminophen; aspirin; codeine phosphate. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; aspirin; codeine phosphate profile page.
Summary for CODEINE, ASPIRIN, APAP FORMULA NO. 4
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CODEINE, ASPIRIN, APAP FORMULA NO. 4 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CODEINE, ASPIRIN, APAP FORMULA NO. 4
US Patents and Regulatory Information for CODEINE, ASPIRIN, APAP FORMULA NO. 4
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scherer Labs | CODEINE, ASPIRIN, APAP FORMULA NO. 4 | acetaminophen; aspirin; codeine phosphate | CAPSULE;ORAL | 085638-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |